Immunotherapy with Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients with Cancer

David Bomze; Daniel Azoulay; Tomer Meirson

doi:10.1001/jamaoncol.2020.0628

Immunotherapy with Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients with Cancer

David Bomze^*, Daniel Azoulay, Tomer Meirson

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

7 Scopus citations

Original language	English
Pages (from-to)	1114-1115
Number of pages	2
Journal	JAMA Oncology
Volume	6
Issue number	7
DOIs	https://doi.org/10.1001/jamaoncol.2020.0628
State	Published - Jul 2020
Externally published	Yes

Funding

Funders	Funder number
Ensign Endowment for Gynecologic Cancer Research
National Institutes of Health
American Cancer Society
National Cancer Institute	NCI CA217685
Breast Cancer Research Foundation
AstraZeneca
Merck	R01CA169121-01A1
Patient-Centered Outcomes Research Institute
Meso Scale Diagnostics

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1001/jamaoncol.2020.0628

Cite this

@article{847c0a55493040128ab59a2aa2ceaa2c,

title = "Immunotherapy with Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients with Cancer",

author = "David Bomze and Daniel Azoulay and Tomer Meirson",

year = "2020",

month = jul,

doi = "10.1001/jamaoncol.2020.0628",

language = "אנגלית",

volume = "6",

pages = "1114--1115",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "7",

}

TY - JOUR

T1 - Immunotherapy with Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients with Cancer

AU - Bomze, David

AU - Azoulay, Daniel

AU - Meirson, Tomer

PY - 2020/7

Y1 - 2020/7

UR - http://www.scopus.com/inward/record.url?scp=85084664263&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2020.0628

DO - 10.1001/jamaoncol.2020.0628

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 32352499

AN - SCOPUS:85084664263

SN - 2374-2437

VL - 6

SP - 1114

EP - 1115

JO - JAMA Oncology

JF - JAMA Oncology

IS - 7

ER -

Immunotherapy with Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients with Cancer

Funding

UN SDGs

Access to Document

Other files and links

Cite this